Browse studies

Find your next paid study

1 recruiting study matching your filters

Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

The goal of this Phase 1 clinical trial is to evaluate the safety and feasibility of nivolumab-IRDye800CW (nivo800) as a molecular imaging agent in adults with…

HnsccHead and NeckSquamous Cell Cancer+8 more

Estimated

~$10 – $6,250

Vanderbilt-Ingram Cancer CenterNCT07460765